CLINICAL_TRIALS
trial_result
· 2025-12-26
Clinical Trial Update: Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/25/1000mg in Healthy Volunteers [Phase 1]
Summary
A Phase 1 pharmacokinetics and safety study of CKD-383 across multiple doses in healthy volunteers has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED